Global Tissue Regeneration Market Research Report

Tissue Regeneration market has been pegged at 1.1m in the year 2013 growing at 12.2% annually and is projected to reach 2m by the end of the year 2018.

Tissue Regeneration constitute 2.5% of Global Biomaterials market and are poised to grow its market share to 2.2% by the end of year 2018.

It is segmented on basis of geographies and products.

What makes our report unique?

• You can request 10% customization in the research matching your exact requirement for e.g. deep dive research in any specific geography or technology or applications.
• This report provides competitive landscape of the top players. Under strategic benchmarking section, we will provide you their key developments along with the impacts including New Product development, M&A, strategic focus on any specific application, technology, geography. Under Financial, we will provide you Capex (Investments), Revenues, EBITDA, etc. Under Operational insights, we will provide you new capacity added, New centers, new key employments. Under sales and marketing, we will provide you insight on new contracts (available on public domain), new distribution channels added, new marketing initiatives, etc.

Key question answered

• What are market estimates and forecasts; which markets are doing well and which are not?
• What is the competitive landscape; who are the main players in each segment; what are their strategic directives, operational strengths, key selling products, and product pipelines? Who is doing what?

Audience for this report

• Tissue Regeneration companies

How below markets are influencing the growth of Tissue Regeneration

• Healthcare Expenditure
• Tissue Regeneration

Top developments

• Medtronic announced first U.S. Implant of Implantable Cardioverter- Defibrillator System Designed to allow Full- Body MRI Scans.
• Stryker completed Acquisition of Berchtold Holding AG
• Medtronic CRT devices got approval to treat Patients with AV Block and reduced Heart function.
• Stryker completed Acquisition of Pivot Medical, Inc.
• Biomet announced Definitive Agreement to Acquire lanx, Inc.
• Biomet announced launch of ePAK Single-Use Delivery System
• Synthes and Lilly signed development and collaboration agreement.
• Synthes Partnered with Materialise in Cranio- Maxillofacial Surgery.
• Increased investments, funds, and grants by government bodies world wide
• Rampant usage of polymers